-
AAAAI: Exclusive Breastfeeding Not Linked to Eczema Risk
drugs
February 26, 2019
Exclusive breastfeeding is not associated with the odds of general eczema diagnosis, but exclusive breastfeeding for three months or longer is associated with reduced odds of continued eczema at age 6.....
-
Glenmark Pharmaceuticals to establish new company in US
pharmaceutical-technology
February 18, 2019
India-based Glenmark Pharmaceuticals is set to spin-off its innovation business into a new company in the US to increase focus on innovation and advance its pipeline towards commercialisation.....
-
J&J still sees plenty of opportunity in crowded immunology markets—starting with psoriasis
fiercepharma
January 13, 2019
Johnson & Johnson knows the immunology market is crowded. But that doesn’t mean it doesn’t still see tons of opportunity there.
-
Velabs Therapeutics to Cooperate with BioMed X in the Field of Immunology
b3cnewswire
January 08, 2019
Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, today announced that it has entered into a collaboration agreement with BioMed X Innovation Center.....
-
Mycenax’s Actemra biosimilar edges closer to approval
pharmaphorum
January 02, 2019
Mycenax’s biosimilar of Roche’s Actemra (tocilizumab), LusiNEX, has been shown to match its originator’s profile in a phase I PK trial, meaning it is on track to become the first approved biosimilar for the drug.
-
Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb join forces to map out lung cancer immunology
firstwordpharma
December 02, 2018
A ‘rule book’ to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments will be created as part of a collaboration between Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb, announc
-
Planning and implementing biomarker testing for immuno-oncology trials
fiercepharma
November 15, 2018
Foundations laid by important cancer biology and immunology research throughout the last decades have led to game-changing clinical breakthroughs in the field of immuno-oncology
-
Startup Gossamer Bio poaches Bristol-Myers Squibb executive as CSO
fiercebiotech
September 06, 2018
Lisa Salter-Cid exits BMS to join the small biotech with big ideas. (Leeroy Agency)
-
UCB and Science 37 partner up for virtual, siteless clinical trials
fiercebiotech
May 07, 2018
UCB announced it will work with Science 37 to bring clinical trials out of brick-and-mortar research sites and into participants’ homes. By using telemedicine, real-world data and outcomes reported by patients via a mobile device...
-
Covance Forms Immunology & Immunotoxicology Unit Focused on Biologic Drug Development
biospace
March 12, 2018
LabCorp®announced today that its Covance Drug Development business has formed a global immunology and immunotoxicology (I&I) unit dedicated to the specific needs of biologic drug development.